Novavax, Inc (NASDAQ: NVAX) is -24.50% lower on its value in year-to-date trading and has touched a low of $4.43 and a high of $23.86 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVAX stock was last observed hovering at around $6.27 in the last trading session, with the day’s loss setting it -0.2%.
Currently trading at $6.07, the stock is -4.99% and -13.51% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.96 million and changing -3.19% at the moment leaves the stock -36.87% off its SMA200. NVAX registered 28.87% gain for a year compared to 6-month loss of -36.84%.
The stock witnessed a -2.72% gain in the last 1 month and extending the period to 3 months gives it a -28.04%, and is -5.45% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.76% over the week and 9.92% over the month.
Novavax, Inc (NVAX) has around 952 employees, a market worth around $983.15M and $682.16M in sales. Fwd P/E is 20.01. Profit margin for the company is -27.49%. Distance from 52-week low is 37.02% and -74.56% from its 52-week high.
The EPS is expected to grow by 159.00% this year.
Novavax, Inc (NVAX) Top Institutional Holders
The shares outstanding are 160.42M, and float is at 147.60M with Short Float at 27.80%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 14.08 million shares valued at $178.19 million. The investor’s holdings represent 9.4861% of the NVAX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.85 million shares valued at $149.98 million to account for 7.984 of the shares outstanding. The other top investors are SHAH CAPITAL MANAGEMENT which holds 9.66 million shares representing 6.5118% and valued at over $122.32 million, while D. E. SHAW & CO., INC. holds 4.2608 of the shares totaling 6.32 million with a market value of $80.04 million.
Novavax, Inc (NVAX) Insider Activity
#####
Novavax, Inc disclosed in a document filed with the SEC on Dec 13 ’24 that King Rachel K. (Director) sold a total of 4,150 shares of the company’s common stock. The trade occurred on Dec 13 ’24 and was made at $9.02 per share for $37435.0. Following the transaction, the insider now directly holds 14770.0 shares of the NVAX stock.
Still, SEC filings show that on Dec 31 ’24, YOUNG JAMES F (Director) disposed off 5,400 shares at an average price of $8.00 for $43200.0. The insider now directly holds 51,760 shares of Novavax, Inc (NVAX).
